Key Highlights
- RKLB shares climbed 11.3% to an intraday peak of $123.94 following Needham’s upgrade, with the firm increasing its price target from $95 to $120 while maintaining a Buy rating.
- Cantor Fitzgerald boosted its target to $96 from $85, highlighting improved launch capabilities and expanding space operations.
- First-quarter revenue reached $200.35 million, marking a 63.4% year-over-year increase and exceeding analyst estimates of $189.65 million.
- Loss per share matched forecasts at -$0.07, with the company updating Q2 projections upward.
- Analyst consensus rates the stock as “Moderate Buy” with an average target price of $91.79.
Rocket Lab USA (RKLB) experienced a remarkable 11.3% rally on Monday after Needham & Company upgraded its price target from $95 to $120 while reaffirming its Buy recommendation.
Shares peaked at $123.94 during intraday trading before closing near $117.35. Trading volume surged to approximately 53 million shares, more than double the typical daily average of 23.3 million.
The momentum followed an impressive first-quarter financial performance. Rocket Lab delivered quarterly revenue of $200.35 million, surpassing the Street’s expectation of $189.65 million and marking a robust 63.4% increase compared to the prior year.
The company reported earnings per share of -$0.07, matching analyst projections. This represents notable progress from the -$0.12 per share loss recorded in the same quarter last year.
Management also upgraded its second-quarter outlook, adding further momentum to investor sentiment.
Wall Street Weighs In
Cantor Fitzgerald added to the optimistic chorus by raising its price objective to $96 from $85 while maintaining an Overweight stance. The firm highlighted Rocket Lab‘s execution excellence and diverse service offerings, spanning the Electron launch vehicle, Haste hypersonic testing platform, and the forthcoming Neutron rocket.
Stifel Nicolaus maintained its Buy recommendation and increased its target from $90 to $105. Bank of America established a $120 price objective. Citigroup confirmed its Outperform rating late last week.
Interestingly, the average consensus price target remains at $91.79, considerably lower than current trading levels. This discrepancy underscores the rapid appreciation in share value.
Among analysts tracking RKLB, two rate it Strong Buy, ten recommend Buy, four suggest Hold, and one advises Sell.
Breaking Down the Q1 Performance
Rocket Lab recorded a negative return on equity of 11.72% and a net margin of -26.87%, typical metrics for an expanding aerospace enterprise.
The first-quarter outperformance stemmed from robust results across both launch services and spacecraft systems divisions. Cantor emphasized the company’s dual-launch infrastructure spanning New Zealand and the United States as a competitive differentiator.
The company maintains a market capitalization of approximately $66.82 billion, a minimal debt-to-equity ratio of 0.02, and a current ratio of 4.47, indicating strong short-term financial health.
The 50-day moving average sits at $72.88, while the 200-day average rests at $68.50, both significantly below present price levels.
Insider activity has trended toward selling. Over the past three months, company insiders divested approximately 233,449 shares valued at more than $16.4 million. SVP Arjun Kampani sold shares in early March at an average price of $69.59, while Director Merline Saintil executed sales at $75.04. Insider ownership currently stands at roughly 8.4%, with institutional investors controlling 71.78%.
Analyst projections point to full-year earnings per share of -$0.22 for the current fiscal period.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
